EurekAlert! -
27 Mar 2020 06:00
(University of Miami Miller School of Medicine) As the COVID-19 pandemic unfolds, inaccurate medical information has flooded social media and other channels. One potentially lethal example is that patients who take renin-angiotensin system (RAS) blockers, particularly angiotensin II type 1 receptor blockers (ARBs), may be more susceptible to the virus.
Share this Article
Comment on this Article
Please to comment